Markets.com Logo

TRVN

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.2773$
  • Previous Close
    0.2773$
  • 52 Week Change
    7.60$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.25$ - 7.85$
  • Dividend Per Share
    --
  • Market cap
    238 K$
  • EPS
    -5.79
  • Beta
    0.404
  • Volume
    --

About

TRVN.US represents the common stock of Trevena, Inc., a biopharmaceutical company focused on the development and commercialization of novel medicines for pain and other central nervous system (CNS) disorders. Trevena's portfolio includes products utilizing its proprietary G protein-biased ligand platform, which aims to selectively target specific receptor signaling pathways to potentially improve therapeutic outcomes and reduce side effects. The company's key marketed product is OLINVYK (oliceridine) injection, an opioid agonist indicated for the management of acute moderate to severe pain in adults. Trevena is also engaged in ongoing research and development activities to expand its pipeline.
EV stocks today: TSLA is going down, Lucid (LCID) stock rises, RIVN drops

EV stocks today: TSLA is going down, Lucid (LCID) stock rises, RIVN drops

Ghko B|--
BTC/USD forecast: Bitcoin drops below $92K, will BTC continue to fall?

BTC/USD forecast: Bitcoin drops below $92K, will BTC continue to fall?

Frances Wang|--
Gold and silver prices hit high: Will XAU/USD and XAG/USD continue to rise?

Gold and silver prices hit high: Will XAU/USD and XAG/USD continue to rise?

Frances Wang|--
Gold prices rose in Saudi Arabia: What's driving the gold price up?

Gold prices rose in Saudi Arabia: What's driving the gold price up?

Ghko B|--
Trending stocks to watch: Netflix, Intel, NIO stock, Tesla (TSLA) stock

Trending stocks to watch: Netflix, Intel, NIO stock, Tesla (TSLA) stock

Ghko B|--
Trending tech stock analysis: Is Super Micro (SMCI) a good stock to buy?

Trending tech stock analysis: Is Super Micro (SMCI) a good stock to buy?

Ghko B|--
NIO stock price prediction 2026: NIO shares jump 1.8%, what’s next?

NIO stock price prediction 2026: NIO shares jump 1.8%, what’s next?

Ghko B|--

Factors

Clinical Trial Results: Positive or negative outcomes from Trevena's clinical trials significantly impact investor confidence and stock price.

Regulatory Decisions: FDA approvals or rejections of Trevena's drug candidates directly influence revenue potential and therefore, stock valuation.

Market Sentiment: General investor optimism or pessimism toward the biotechnology sector can affect the demand and price of TRVN.US.

Financial Performance: Trevena's revenue, expenses, cash flow, and debt levels influence investor perceptions of the company's stability and growth prospects.

Competition: The presence and success of competing drugs can impact Trevena's market share and potential profitability.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

Futures CFDs trading: What is futures trading, how to trade futures?

Futures CFDs trading: What is futures trading, how to trade futures?

Ghko B|--
Crypto trading basics: How to use free crypto signals, why they are popular?

Crypto trading basics: How to use free crypto signals, why they are popular?

Ghko B|--
Beginner's guide to CFD trading: How to trade CFDs in six steps?

Beginner's guide to CFD trading: How to trade CFDs in six steps?

Ghko B|--